Metropolitan Life Insurance Company (MetLife)’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-133
Closed -$11K 2398
2023
Q3
$11K Hold
133
﹤0.01% 2171
2023
Q2
$12.7K Buy
133
+65
+96% +$8.34K ﹤0.01% 2173
2023
Q1
$9.42K Sell
68
-94
-58% -$8.6K ﹤0.01% 2181
2022
Q4
$11.6K Hold
162
﹤0.01% 2238
2022
Q3
$19.1K Hold
162
﹤0.01% 2051
2022
Q2
$29.6K Hold
162
﹤0.01% 1828
2022
Q1
$38K Sell
162
-481
-75% -$97.1K ﹤0.01% 1743
2021
Q4
$219K Buy
643
+219
+52% +$121K ﹤0.01% 1968
2021
Q3
$277K Sell
424
-74
-15% -$54.4K ﹤0.01% 1834
2021
Q2
$499K Buy
+498
New +$496K 0.01% 1527

Other funds holding DNMR

Metropolitan Life Insurance Company (MetLife)'s DNMR Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Danimer Scientific, Inc. (DNMR) in Q4 2023, closing a stake of 133 shares — an estimated $11K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DNMR in Q2 2021 and held it in 10 quarters. The position peaked at $499K in Q2 2021. 140 funds tracked by Wall St. Rank hold DNMR as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Danimer Scientific, Inc. position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 133 Danimer Scientific, Inc. shares in Q4 2023, an estimated $11K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Danimer Scientific, Inc. position peaked at $499K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.